{"adrenal insufficiency": 9.38, "alanine aminotransferase increased": 3.44, "amylase increased": 3.54, "anal fistula": 10.59, "aortic dissection": 6.3, "ascites": 5.2, "aspartate aminotransferase increased": 4.08, "blister": 2.04, "blood albumin decreased": 4.71, "blood calcium decreased": 4.64, "blood pressure increased": 3.38, "blood thyroid stimulating hormone increased": 12.9, "bone lesion": 8.56, "cancer pain": 28.32, "cholangitis": 7.55, "cholecystitis": 2.21, "clear cell renal cell carcinoma": 23.34, "colitis": 2.5, "constipation": 3.12, "decreased appetite": 6.44, "dehydration": 2.52, "dermatitis acneiform": 5.43, "diarrhoea": 5.39, "disease progression": 12.03, "dry skin": 5.47, "dysgeusia": 3.27, "dysphonia": 5.98, "enterocolitis": 3.32, "gastric ulcer": 2.04, "gastrointestinal perforation": 12.44, "gastrointestinal toxicity": 7.13, "general physical health deterioration": 2.14, "glossodynia": 2.7, "hair colour changes": 25.49, "hepatic cytolysis": 2.56, "hepatic encephalopathy": 7.83, "hepatic enzyme increased": 2.25, "hepatic function abnormal": 9.04, "hepatocellular carcinoma": 43.75, "hepatotoxicity": 3.11, "hyperkeratosis": 15.66, "hypertension": 7.04, "hyperthyroidism": 4.93, "hypertransaminasaemia": 6.21, "hypoalbuminaemia": 5.11, "hypocalcaemia": 7.73, "hypomagnesaemia": 10.39, "hypothyroidism": 35.23, "immune-mediated enterocolitis": 4.89, "immune-mediated hepatic disorder": 11.69, "immune-mediated lung disease": 5.24, "impaired healing": 9.51, "inappropriate schedule of product administration": 3.11, "interstitial lung disease": 3.85, "intestinal metastasis": 41.56, "intestinal perforation": 5.03, "laboratory test abnormal": 2.36, "large intestine perforation": 9.41, "liver disorder": 7.13, "liver function test increased": 3.79, "maligt neoplasm progression": 14.45, "maligt pleural effusion": 12.24, "metastases to bone": 19.34, "metastases to central nervous system": 9.68, "metastases to liver": 6.28, "metastases to lung": 19.67, "metastases to lymph nodes": 6.65, "metastases to pancreas": 48.89, "metastases to spine": 15.1, "metastasis": 3.45, "metastatic renal cell carcinoma": 22.89, "mucosal inflammation": 15.3, "nephrotic syndrome": 6.54, "off label use": 2.14, "oral pain": 4.43, "osteonecrosis of jaw": 20.16, "palmar-plantar erythrodysaesthesia syndrome": 94.51, "performance status decreased": 3.73, "platelet count decreased": 3.4, "pleural effusion": 2.28, "pneumatosis intestinalis": 11.42, "pneumonia aspiration": 2.25, "pneumonia bacterial": 4.15, "pneumothorax": 3.02, "posterior reversible encephalopathy syndrome": 5.21, "product prescribing issue": 3.78, "protein urine present": 16.53, "proteinuria": 33.88, "pulmonary mass": 2.5, "renal cancer metastatic": 59.87, "renal cell carcinoma": 104.0, "renal cell carcinoma recurrent": 168.75, "renal impairment": 3.55, "skin disorder": 2.46, "skin exfoliation": 2.2, "skin toxicity": 17.61, "skin ulcer": 9.1, "small intestinal perforation": 13.68, "stomatitis": 15.45, "taste disorder": 14.55, "thyroid disorder": 6.15, "thyroiditis": 9.24, "tooth disorder": 3.75, "transaminases increased": 2.14, "tumour haemorrhage": 9.79, "tumour necrosis": 22.35, "weight decreased": 4.48}